Simvastatin Niacin Extended Release Articles
Abbott Labs files suit against Impax over Simcor patent challenge; Ranbaxy debuts generic Aricept in USA
29 November 2010
Solvay viewing options for pharma
2 April 2009
Negative press has compromised Vytorin as first-line therapy; DR
17 November 2008
Solvay's 9-month profit down 34% on Fortis
10 November 2008
Solvay's first-half 2008 profit declines 15%
11 August 2008
Solvay's 1st-qtr 2008 net income rises 1%
26 May 2008
Abbott reports 35% rise in earnings
28 April 2008
Abbott gets $100M under Simcor deal
24 March 2008
Abbott's Simcor gets FDA approval as cholesterol control treatment
25 February 2008
Solvay to co-promote Abbott's Simcor in USA
29 October 2007
Abbott Labs submits US NDA for Simcor
30 April 2007
Showing 1-15 of 15 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
